Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Medicine prices, availability, and affordability in 36 developing and middle-income countries

A secondary analysis

Bibliographic Data

ID23364323
AuthorsA Cameron (0000-0003-3585-3874), Margaret Ewen (0000-0003-1177-4717, Health Action International), Dennis Ross-Degnan (0000-0002-0066-1242, Harvard University), Douglas Ball (0000-0001-5628-0169), Richard Laing (0000-0002-3825-217X, World Health Organization)
Year2009
Volume373
Issue9659
Pages240-249
Publication date2009-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueThe Lancet (JOURNAL)
Journal identifiersISSN: 0099-5355 • E-ISSN: 0140-6736
PublisherElsevier BV (PUBLISHER)
DOI10.1016/s0140-6736(08)61762-6
PMID19042012
OpenAlexW2122047846
LanguageEN
Citations received72
References cited6

Business · Developing country · Economic growth · Economics · Economy · Exchange rate · Government procurement · Inflation (cosmology) · Macroeconomics · Monetary economics · Private sector · Procurement · Public sector · Purchasing · Purchasing power · Purchasing power parity · Economic and Financial Impacts of Cancer · Health Systems, Economic Evaluations, Quality of Life · Marketing · Pharmaceutical Economics and Policy

  • Canada and access to medicines in developing countries

    Open Access•Joel Lexchin•Globalization and Health•2013

  • Factors influencing global antiretroviral procurement prices

    Open Access•Veronika J Wirtz, Steven Forsythe et al.•BMC Public Health•2009

  • Precios, disponibilidad y asequibilidad de insulina en farmacias públicas y privadas en Perú

    Open Access•Janeth Tenorio-Mucha, Janeth Tenorio‐Mucha et al.•Revista Panamericana de Salud…•2019

  • Capacidade aquisitiva e disponibilidade de medicamentos para doenças crônicas no setor público

    Open Access•Ana Paula Helfer, Aline Lins Camargo et al.•Revista Panamericana de Salud…•2012

  • Measuring medicine prices in Peru

    Open Access•J M Madden, Edson Meza et al.•Revista Panamericana de Salud…•2010

  • A comparative analysis of medicine prices in Latin America

    Roberto Álvarez E, Aldo González•CEPAL review•2020

  • Togo to Go

    Open Access•Nassifatou Koko Tittikpina, Chukwunonso E C C Ejike et al.•African Journal of Traditional…•2015

  • Trends and Challenges of Traditional Medicine in Africa

    Open Access•AA Abdullahi•African Journal of Traditional…•2011

  • Togo to go

    Open Access•Nassifatou Koko Tittikpina, Chukwunonso E C C Ejike et al.•African Journal of Traditional…•2017

  • Acesso a medicamentos no setor público

    Open Access•Alexandra Crispim Boing, Andréa Dâmaso Bertoldi et al.•Cadernos de Saude Publica•2013

  • Brazilian generics market change after Farmácia Popular program

    Open Access•Andréa Dâmaso Bertoldi, Luisa Arueira Chaves et al.•Revista de Saúde Pública•2019

  • Access to sexual and reproductive health commodities in East and Southern Africa

    Open Access•Gaby I Ooms, Denis Kibira et al.•BMC Public Health•2020

  • Availability and affordability of children essential medicines in health facilities of southern nations, nationalities, and people region, Ethiopia

    Open Access•Tefera Tadesse, Habtamu Abuye et al.•BMC Public Health•2021

  • Hypertension in developing countries

    Open Access•M Mohsen Ibrahim, Albertino Damasceno•The Lancet•2012

  • Essential medicines for universal health coverage

    Open Access•Veronika J Wirtz, Hans V Hogerzeil et al.•The Lancet•2017

  • Constructing a malaria-related health service readiness index and assessing its association with child malaria mortality

    Open Access•Ourohiré Millogo, Jean Edouard Odilon Doamba et al.•BMC Public Health•2021

  • Availability of Essential Medicines in a Country in Conflict

    Open Access•Mohamed Izham Mohamed Ibrahim, Mohammed Alshakka et al.•International Journal of…•2020

  • Unveiling the unseen toll

    Open Access•Michelle Cherfane, Myriam Boueri et al.•BMC Public Health•2024

  • Prices and Affordability of Essential Medicines in 72 Low-, Middle-, and High-Income Markets

    Open Access•Olivier J Wouters, Cyprien Denolle et al.•JAMA Health Forum•2025

  • Essential Medicines at the National Level

    Open Access•Karen Bissell, Philippa Ellwood et al.•International Journal of…•2019

  • Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases

    Open Access•Saval Khanal, Lennert Veerman et al.•INQUIRY The Journal of Health…•2019

  • Evaluating the Price, Availability, and Affordability of Essential Medicines in Primary Healthcare Institutions

    Open Access•Xiao Wang, Xuan He et al.•Frontiers in Public Health•2022

  • Structural Factors Responsible for Universal Health Coverage in Low- and Middle-Income Countries

    Open Access•Chhabi Lal Ranabhat, Mihajlo Jakovljević et al.•Frontiers in Public Health•2020

  • The Effects of the National Centralized Drug Purchasing Pilot Program on Nucleos(t)ide Analogs in Shenzhen City

    Open Access•Xiaotong Wen, Shicheng Yin et al.•Frontiers in Public Health•2021

  • Access to anticancer medicines in public hospitals of Northwestern China

    Open Access•Yue Ma, Jin Peng et al.•Frontiers in Public Health•2023

  • Improving access to medicines and beyond

    Open Access•Zheng Zhu, Quan Wang et al.•BMJ Global Health•2023

  • Essential medicine shortages, procurement process and supplier response

    Open Access•Vijaya Chebolu-Subramanian, R P Sundarraj•Social Science & Medicine•2021

  • Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda

    Open Access•Davis Kibirige, David Atuhe et al.•International Journal for Equity…•2017

  • Prices of medicines for the management of pain, diabetes and cardiovascular diseases in private pharmacies and the national health insurance in Tanzania

    Open Access•Rashid Bakari Kirua, Mary Temu et al.•International Journal for Equity…•2020

  • Accessibility crisis of essential medicines at Sudanese primary healthcare facilities

    Open Access•Lina Hemmeda, Abubaker Koko et al.•International Journal for Equity…•2023

  • The imperative for systems thinking to promote access to medicines, efficient delivery, and cost-effectiveness when implementing health financing reforms

    Open Access•Tom Achoki, Abaleng Lesego•International Journal for Equity…•2017

  • Barriers in household access to medicines for chronic conditions in three Latin American countries

    Open Access•Isabel Emmerick, Isabel Cristina Martins Emmerick et al.•International Journal for Equity…•2015

  • A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals

    Open Access•Xiaodong Guan, Huajie Hu et al.•International Journal for Equity…•2018

  • Strengthening regulation for medical products in Tanzania

    Open Access•Adam M Fimbo, Hiiti B Sillo et al.•PLOS Global Public Health•2024

  • A socio-ecological framework examination of drivers of blood pressure control among patients with comorbidities and on treatment in two Nairobi slums; a qualitative study

    Open Access•Shukri F Mohamed, Teresia Macharia et al.•PLOS Global Public Health•2023

  • Beyond patents

    Open Access•Mark Eccleston-Turner•Ethics Medicine and Public Health•2017

  • Availability, prices and affordability of essential medicines in Haiti

    Open Access•Harinder Singh Chahal, Nazaire St Fort et al.•Journal of Global Health•2013

  • Inequalities in disease burden and care quality of chronic obstructive pulmonary disease, 1990–2021

    Open Access•Lingzi Yao, Jin Cao et al.•Journal of Global Health•2024

  • Priority-setting, the Indian way

    Open Access•Neethi Rao, Neethi V Rao et al.•Journal of Global Health•2018

  • The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement

    Open Access•Quan Wang, Siqi Liu et al.•Journal of Global Health•2023

  • A win-win solution

    Open Access•Suerie Moon, Elodie Jambert et al.•Globalization and Health•2011

  • Local production of pharmaceuticals in Africa and access to essential medicines

    Open Access•Phares GM Mujinja, Maureen Mackintosh et al.•Globalization and Health•2014

  • Availability, prices and affordability of the World Health Organization’s essential medicines for children in Guatemala

    Open Access•Angela Anson, Brooke M Ramay et al.•Globalization and Health•2012

  • Medicines availability for non-communicable diseases

    Open Access•Jane Robertson, Cécile Macé et al.•Globalization and Health•2015

  • Is the Brazilian pharmaceutical policy ensuring population access to essential medicines

    Open Access•Andréa Dâmaso Bertoldi, Andréa Bertoldi et al.•Globalization and Health•2012

  • Assessment of the scope and practice of evaluation among medical donation programs

    Open Access•Alisa Jenny, Alisa M Jenny et al.•Globalization and Health•2016

  • Pharmacogenomic technologies

    Open Access•Catherine Olivier, Bryn Williams–Jones et al.•Globalization and Health•2011

  • The role of law and governance reform in the global response to non-communicable diseases

    Open Access•Roger Magnusson, Roger S Magnusson et al.•Globalization and Health•2014

  • Logics of acquiring medicines from informal retailers in four African countries

    Open Access•Janelle Wagnild, Samuel Asiedu Owusu et al.•Global Health Action•2025

  • Cancer control in developing countries

    Open Access•Timothy P Hanna, Alfred CT Kangolle et al.•BMC International Health and…•2010

  • Access to Medicines and Distributive Justice

    Open Access•Rachel Kiddell‐Monroe•Developing World Bioethics•2014

  • Resource shortage in public health facilities and private pharmacy practices in Odisha, India

    Open Access•Bijetri Bose, Terence Chai Cheng et al.•Health Policy and Planning•2024

  • Testing the unintended cost effects of health policies for generic substitutions

    Open Access•Boya Zhao, Jing Wu et al.•Health Policy and Planning•2025

  • Prevalência do consumo de medicamentos em adultos brasileiros

    Open Access•Vanessa Pereira Gomes, Marcus Tolentino Silva et al.•Ciência & Saúde Coletiva•2017

  • Demandas judiciais por medicamentos antineoplásicos

    Open Access•Thaís Jeronimo Vidal, Elaine Lazzaroni Moraes et al.•Ciência & Saúde Coletiva•2017

  • Impacto de una política de medicamentos integrada y centralizada

    Open Access•Gustavo H Marin, Ayelén P Capallo et al.•Revista Panamericana de Salud…•2026

  • Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries

    Open Access•Catherine E Vialle-Valentin, Catherine Vialle-Valentin et al.•Health Policy and Planning•2015

  • Inflated medicine prices in Vietnam

    Open Access•Thanh An Nguyen, Tuan Anh Nguyen et al.•Health Policy and Planning•2017

  • Defining pharmaceutical systems strengthening

    Open Access•Tamara Hafner, Helena Walkowiak et al.•Health Policy and Planning•2016

  • The availability, price and affordability of antidiabetic drugs in Hubei province, China

    Open Access•Shiwei Gong, Hongbing Cai et al.•Health Policy and Planning•2018

  • Access to medicines from a health system perspective

    Open Access•Maryam Bigdeli, Bart Jacobs et al.•Health Policy and Planning•2013

  • Progress in increasing affordability of medicines for non-communicable diseases since the introduction of mandatory health insurance in the Republic of Moldova

    Open Access•Alessandra Ferrario, Elena Chitan et al.•Health Policy and Planning•2016

  • How does performance-based financing affect the availability of essential medicines in Cameroon? A qualitative study

    Open Access•Isidore Sieleunou, Anne-Marie Turcotte-Tremblay et al.•Health Policy and Planning•2019

  • Who bears the cost of ‘informal mhealth’? Health-workers’ mobile phone practices and associated political-moral economies of care in Ghana and Malawi

    Open Access•K Hampshire, G Porter et al.•Health Policy and Planning•2017

  • Factors that influence the scale up of new interventions in low-income settings

    Open Access•Jennifer A Callaghan-Koru, Munia Islam et al.•Health Policy and Planning•2020

  • The effects of medicines availability and stock-outs on household’s utilization of healthcare services in Dodoma region, Tanzania

    Open Access•August Kuwawenaruwa, Kaspar Wy et al.•Health Policy and Planning•2020

  • Path

    Michael Stevenson•Third World Quarterly•2017

  • Applying the Essential Medicines Concept to US Preferred Drug Lists

    Timothy P Millar, Shirley Wong et al.•American Journal of Public Health•2011

  • Re-Thinking Pharmaceutical Production in Africa; Insights from the Analysis of the Local Manufacturing Dynamics in Mozambique and Zimbabwe

    Open Access•Giuliano Russo, Geoffrey Banda•Studies in Comparative…•2015

  • Preços e disponibilidade de medicamentos no Programa Farmácia Popular do Brasil

    Open Access•Cláudia Du Bocage Santos Pinto, Elaine Silva Miranda et al.•Revista de Saúde Pública•2010

  • Access to Controlled Medications

    Open Access•Willem Scholten•Journal of Illicit Economies and…•2020

  • Utilização e fontes de obtenção de medicamentos

    Open Access•Kelerson Semerene Costa, Karen Sarmento Costa et al.•Cadernos de Saude Publica•2016

Unique citing works72
Citations per year4,24
Citation span2009 - 2026 (18)
Citation velocitycurrent
Highly citedNo
Citation typesNeutral: 61
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae